At the single-cell level, improved oxygenation synergizes with PD-1/PD-L1 inhibitors, cancer vaccines, and adoptive T cell transfer by enhancing antigen presentation, limiting T cell exhaustion, and increasing effector cytokine production (61). The gene discussed is CD274; the disease is cancer.